221results about How to "Avoid harmful effects" patented technology

A hemostatic device includes a flexible band adapted to be wrapped around a patient's limb at a site on the limb where bleeding is to be stopped, a portion for securing the band in a wrapped state to the limb, a curved plate which is made of a material more rigid than the band and at least a portion of which is curved toward the inner peripheral side thereof, a main balloon which is provided on the inner peripheral side of the curved plate and which inflates when a fluid is introduced therein, and a pressing member which is provided between the curved plate and the main balloon so that at least a portion thereof overlaps with the balloon and which is adapted for pressing against the balloon. The device provides an excellent hemostatic effect and prevents numbness and poor circulation in areas peripheral to the site of attachment.

The present invention provides a portable patient turning and lifting device and associated methods for turning and lifting an immobilized patient. The device comprises at least one inflation bladder configured to be secured between the patient's body and the patient supporting surface, such as a bed. The bladder is inflated with pressurized fluid. Preferably, the inflation bladder is secured by a body support having at least one support pad on which the patient is positioned. An embodiment provides two inflatable turning bladders oriented on the left and right sides of the back of the body support. Preferably, at least one fluid pump is provided in communication with the bladders, and it is preferably fitted with a controller to tailor the sequencing and timing of the inflation to reposition the patient's body.

The toothbrush can prevent harmful effects that the conventional toothbrushes frequently give and is composed of disintegratable or replaceable parts, so that a user can select an optimum toothbrush by combining suitable parts depending on the individual user's specificity. The toothbrush contains a head having bristles implanted therein, a neck having the head attached to the distal end thereof and a holder for holding the neck. The head is a single piece or is composed of a plurality of head segments. The holder is provided at the distal end thereof with an adjuster for adjusting the length of the neck protruding from the holder.

The invention discloses a vacuum formation method of a lithium ion battery. In the method, an electrolyte injection process and a formation process of the battery are completed by adopting an integrated fixture with electrolyte-injecting and charging functions and a vacuum formation device with charging and vacuumizing functions. The vacuum formation device charges the battery arranged in the integrated fixture, and the battery is electrically connected with the vacuum formation device by the integrated fixture. The vacuum formation method of the invention provides an enclosed and controllable microenvironment, thereby reducing electrolyte waste, avoiding overflow loss of electrolyte and corrosion on a battery casing, the fixture or charging equipment, and effectively reducing environmental pollution.

A method of prevention/treatment of pathological consequences of DNA damage triggered by incorporation of circulating apoptotic chromatin fragments into healthy cells of individuals/patients in need therefore, said method comprising ex vivo or extra corporeal treatment of blood/plasma for removal of circulating chromatin fragments released from apoptotic cells which apoptotic chromatin fragments are capable of triggering DNA damage leading to genomic instability, senescence, apoptosis and cancerous transformation of healthy cells on being integrated into their genomes

An apparatus for treating polymeric materials comprises a treatment chamber adapted to maintain a selected atmosphere; a means for supporting the polymeric material within the chamber; and, a source of plasma-derived gas containing at least one reactive oxidative species whereby the polymer is stabilized and cross linked through exposure to the oxidative species in the chamber at a selected temperature. The polymer may be directly exposed to the plasma, or alternatively, the plasma may be established in a separate volume from which the reactive species may be extracted and introduced into the vicinity of the polymer. The apparatus may be configured for either batch-type or continuous-type processing. The apparatus and method are especially useful for preparing polymer fibers, particularly PAN fibers, for later carbonization treatments.

When DDoS attack packets are transmitted from the attacker to the victim's server, the attack packets are detected in the edge router of the LAN accommodating the server. These packets are then destroyed, the address of the upstream routers close to the attack source are retrieved, and attack source retrieval modules are transmitted from the edge router to all the upstream routers. By executing the retrieval modules in the upstream routers, verification is performed as to whether the attack packets are passing through those upstream routers. The results are notified to the transmission source router and if the attack packets are passing through, the retrieval modules are transmitted to routers at the upper stream. When the router at the uppermost stream is reached, a protection module is executed to destroy the attack packets. When the attacks cease, the protection module deletes itself and the protection process is ended.

The present invention provides novel biomaterials comprising one or more of Mg, Zn and F ions in a carbonate-containing biphasic calcium phosphate (BCP) system. The biomaterial may contain Mg, Zn, F, Mg and Zn, Mg and F, Zn and F, or Mg, Zn and F. The biomaterial may be substantially similar in composition to bone mineral (a carbonate apatite). The biomaterial may feature slow release of Mg, Zn, F, Ca, and P ions. The biphasic calcium phosphate, BCP, may be a mixture of unsubstituted hydroxyapatite (HA) and unsubstituted .-TCP, Ca₃(PO₄)₂. BCP of varying HA/.-TCP ratios may be produced by sintering calcium-deficient apatite, for instance having a Ca/P<1.5, 1.6, 1.67, 1.75 or 1.8 that has been prepared either by a precipitation or by a hydrolysis method or by a solid-state reaction. The amount of each component (by weight %) present in the biomaterials may be as follows: Mg 0.5 to 12 wt %, Zn 1 to 12 wt %, F 0.1 to 4 wt %, calcium 20 to 40 wt %, phosphate 10 to 20 wt %, and carbonate (CO₃) 1 to 20 wt %. The biomaterial may further comprise one or more other ion such as strontium, manganese, copper, boron or silicate, or one or more other organic moiety such as a protein, a peptide, or a nutraceutical which may provide antioxidant, anti-bacterial or anti-inflammatory properties. The invention also provides methods of inhibiting bone resorption, methods of treating osteoporosis or delaying the onset of osteoporosis, methods of treating a bone fracture, and methods of inhibiting osteoclast activity. Further, the invention provides methods of treating or reversing bone deficiencies such as bone loss, similar to osteoporosis, caused all or in part by a mineral deficient diet, a disease such as cancer or osteopenia, a treatment such as steroid therapy or radiation therapy, or a physical condition such as immobilization.

In an ink jet recording apparatus, it is detected whether or not an ejection has been performed at least one time while printing an image, with respect to each nozzle, within a predetermined period (preliminary on-paper ejection cycle corresponding to the checking area C1), and the nozzle which has performed the ejection at least one time is excluded from a target of preliminary ejection within a second predetermined period (preliminary on-paper ejection cycle corresponding to the checking area C2) subsequent to the above predetermined period. As for the nozzle not excluded from the preliminary ejection target, the preliminary ejection is performed at least one time onto paper (preliminary on-paper ejection area R2) as to each nozzle at a predetermined timing within the second predetermined period (preliminary on-paper ejection cycle corresponding to the checking area C2). Accordingly, printing is not interrupted by a head recovery processing, and also unnecessary preliminary ejection can be reduced. In the case of a recording medium such as cardboard and envelope, which is processed after recording and changed in shape so as to functionate as desired, the preliminary ejection is performed onto a position defined according to the shape, for example, flap portion (206C), overlap portion (206A), and the like, without exceeding a predetermined density.

Use of a composition which contains at least one semifluorinated alkane compound and at least one liquid siloxane, wherein the composition is of a density in a range of 0.8 to 1.5 g/cm³, for preserving organs or limbs.

P-type active region 12; n-type source/drain regions 13a and 13b; gate insulating film 14 made of a thermal oxide film; gate electrode 15; source/drain electrodes 16a and 16b, are provided over a p-type SiC substrate 11. In the active region 12, p-type heavily doped layers 12a, which are thin enough to create a quantum effect, and thick undoped layers 12b are alternately stacked. When carriers flow, scattering of impurity ions in the active region is reduced, and the channel mobility increases. In the OFF state, a depletion layer expands throughout the active region, and the breakdown voltage increases. As a result of reduction in charges trapped in the gate insulating film or near the interface between the gate insulating film and the active region, the channel mobility further increases.

1. An aromatic amino acid derivative represented by the formula (I) or its pharmacologically acceptable salt:

wherein,

• [0001]
  • R¹ is a hydrogen atom or an amino-protecting group,
  [0002]
  • R² is a halogen atom or an alkyl, aralkyl or aryl group,
  [0003]
  • R³ is {circle over (1)} a hydrogen atom, {circle over (2)} an aroylamino group, {circle over (3)} a phenyl group substituted with lower alkyl, phenyl, phenoxy, etc. {circle over (4)} a naphthyl or tetrahydronaphthyl group optionally substituted with hydroxy, lower alkoxy or di(lower)alkylamino, {circle over (5)} an unsaturated mono-cyclic heterocyclic group containing N, O and/or S substituted with lower alkyl, phenyl, naphthyl or tetrahydroquinolyl, {circle over (6)} an unsaturated or partially saturated condensed heterocyclic group containing N, O and/or S, optionally substituted with oxo, carboxy, amino, lower alkyl, etc.; X is a halogen atom, an alkyl group or an alkoxy group; Y is oxygen atom or nitrogen atom; I is 0 or 1; m is 0, 1 or 2; n is an integer of 0-5. This compound can inhibit a transporter (LAT1) of essential amino acid which is one of main nutrition for cancer cells and accordingly cause drain of the essential amino acid on the cancer cells and finally can prohibit the multiplication of cancer cells.

Disclosed is the use of a composition comprising a combination of diacylglycerol(s) (DAG), mainly 1,3-diacylglycerol(s), and phytosterol and/or phytostanol ester(s) (PSE) dissolved or dispersed in edible oil and/or edible fat, particularly olive, canola and fish oil, in the manufacture of nutritional supplements and orally administrable pharmaceutical preparations which are capable of reducing blood levels of both cholesterol and triglycerides and/or for lowering serum, serum LDL and macrophage oxidation levels, inhibiting the formation of foam cells and/or preventing the deleterious effects generated by lipid-induced oxidative stress. In addition, the composition of the invention, as well as the pharmaceutical preparations thereof, are suitable for the treatment and prevention of conditions related to atherosclerosis, such as cardiovascular disease (CVD), coronary heart disease (CHD) and diabetes mellitus.

This invention relates generally to a therapeutic medical garment that supports the abdomen or belly of a pregnant or post-partum woman and of either men or women with distended abdomens. The invention relates to an adjustable-support therapeutic undergarment which lifts the abdomen to prevent irritation of a surgical incision or scar in the lower abdominal or groin region such an incision resulting from a caesarian section or a hernia incision. The invention allows proper healing of the incision, and relieves both stress and strain on the scar and friction from the overhanging abdomen.